310 related articles for article (PubMed ID: 21468919)
1. Crystal forms of naproxen.
Song JS; Sohn YT
Arch Pharm Res; 2011 Jan; 34(1):87-90. PubMed ID: 21468919
[TBL] [Abstract][Full Text] [Related]
2. Crystal forms of SK-3530.
Song HO; Sohn YT
Arch Pharm Res; 2010 Dec; 33(12):2033-6. PubMed ID: 21191770
[TBL] [Abstract][Full Text] [Related]
3. Crystal forms of atorvastatin.
An SG; Sohn YT
Arch Pharm Res; 2009 Jun; 32(6):933-6. PubMed ID: 19557372
[TBL] [Abstract][Full Text] [Related]
4. Solid state of CG-400549, a novel FabI inhibitor: characterization, dissolution, transformation.
Kim BY; Sohn YT
Arch Pharm Res; 2011 May; 34(5):775-9. PubMed ID: 21656363
[TBL] [Abstract][Full Text] [Related]
5. Crystal form of cephradine.
Sohn YT; Park SH
Arch Pharm Res; 2006 Feb; 29(2):178-82. PubMed ID: 16526284
[TBL] [Abstract][Full Text] [Related]
6. An investigation into the effect of spray drying temperature and atomizing conditions on miscibility, physical stability, and performance of naproxen-PVP K 25 solid dispersions.
Paudel A; Loyson Y; Van den Mooter G
J Pharm Sci; 2013 Apr; 102(4):1249-67. PubMed ID: 23359268
[TBL] [Abstract][Full Text] [Related]
7. Changes in the solid state of anhydrous and hydrated forms of sodium naproxen under different grinding and environmental conditions: Evidence of the formation of new hydrated forms.
Censi R; Rascioni R; Di Martino P
Eur J Pharm Biopharm; 2015 May; 92():192-203. PubMed ID: 25796350
[TBL] [Abstract][Full Text] [Related]
8. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
[TBL] [Abstract][Full Text] [Related]
9. Coamorphous drug systems: enhanced physical stability and dissolution rate of indomethacin and naproxen.
Löbmann K; Laitinen R; Grohganz H; Gordon KC; Strachan C; Rades T
Mol Pharm; 2011 Oct; 8(5):1919-28. PubMed ID: 21815614
[TBL] [Abstract][Full Text] [Related]
10. Stability of polymorphic forms of ranitidine hydrochloride.
Wu V; Rades T; Saville DJ
Pharmazie; 2000 Jul; 55(7):508-12. PubMed ID: 10944778
[TBL] [Abstract][Full Text] [Related]
11. Characterization of two polymorphs of lornoxicam.
Zhang J; Tan X; Gao J; Fan W; Gao Y; Qian S
J Pharm Pharmacol; 2013 Jan; 65(1):44-52. PubMed ID: 23215687
[TBL] [Abstract][Full Text] [Related]
12. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
13. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
14. Crystal growth formation in melt extrudates.
Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
[TBL] [Abstract][Full Text] [Related]
15. Physical characterization of naproxen sodium hydrate and anhydrate forms.
Di Martino P; Barthélémy C; Palmieri GF; Martelli S
Eur J Pharm Sci; 2001 Dec; 14(4):293-300. PubMed ID: 11684403
[TBL] [Abstract][Full Text] [Related]
16. The solid state of rebamipide: preparation, characterization, and dissolution.
Jeon SH; Sohn YT
Arch Pharm Res; 2016 Apr; 39(4):508-515. PubMed ID: 26897596
[TBL] [Abstract][Full Text] [Related]
17. Influence of pH and method of crystallization on the solid physical form of indomethacin.
Dubbini A; Censi R; Martena V; Hoti E; Ricciutelli M; Malaj L; Di Martino P
Int J Pharm; 2014 Oct; 473(1-2):536-44. PubMed ID: 25064728
[TBL] [Abstract][Full Text] [Related]
18. A new tetrahydrated form of sodium naproxen.
Di Martino P; Barthélémy C; Joiris E; Capsoni D; Masic A; Massarotti V; Gobetto R; Bini M; Martelli S
J Pharm Sci; 2007 Jan; 96(1):156-67. PubMed ID: 16960825
[TBL] [Abstract][Full Text] [Related]
19. Diclofenac solubility: independent determination of the intrinsic solubility of three crystal forms.
Llinàs A; Burley JC; Box KJ; Glen RC; Goodman JM
J Med Chem; 2007 Mar; 50(5):979-83. PubMed ID: 17298048
[TBL] [Abstract][Full Text] [Related]
20. Polymorphism and pseudopolymorphism of acyclovir.
Sohn YT; Kim SH
Arch Pharm Res; 2008 Feb; 31(2):231-4. PubMed ID: 18365695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
